Drug Shortage Report for ABILIFY
| Report ID | 141232 |
| Drug Identification Number | 02322404 |
| Brand name | ABILIFY |
| Common or Proper name | Abilify |
| Company Name | OTSUKA PHARMACEUTICAL CO LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ARIPIPRAZOLE |
| Strength(s) | 15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | bottle format |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2021-08-16 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2021-10-12 |
| Shortage status | Resolved |
| Updated date | 2021-10-13 |
| Company comments | Resolved |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-10-13 | English | Compare |
| v5 | 2021-10-12 | French | Compare |
| v4 | 2021-10-12 | English | Compare |
| v3 | 2021-08-17 | English | Compare |
| v2 | 2021-06-18 | French | Compare |
| v1 | 2021-06-18 | English | Compare |
Showing 1 to 6 of 6